| |
| |
|
| Insider
Information: |
Cohen Chad M |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
56,286 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$97,602 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,286 |
|
|
| Total
Value |
$97,602 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zillow Group Inc |
Z |
CFO & Treasurer |
2015-02-18 |
183 |
2015-02-17 |
0 |
Premium* |
|
|
Trupanion Inc. |
TRUP |
Director |
2019-03-31 |
4,119 |
2018-03-31 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Chief Financial Officer |
2021-12-22 |
21,604 |
2019-07-01 |
0 |
Premium* |
|
|
Vacasa, Inc. |
VCSA |
Director |
2024-05-21 |
30,380 |
2022-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-09 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-10 |
4 |
AS |
$33.93 |
$169,650 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-10 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| TRUP |
Trupanion Inc. |
Director |
– • – |
2018-11-27 |
4 |
OE |
$8.57 |
$55,928 |
D/D |
6,526 |
8,911 |
0 |
- |
|
| TRUP |
Trupanion Inc. |
Director |
– • – |
2018-11-27 |
4 |
S |
$27.30 |
$178,168 |
D/D |
(6,526) |
2,385 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-09-11 |
4 |
AS |
$40.00 |
$343,520 |
D/D |
(8,588) |
1,000 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-09-11 |
4 |
OE |
$6.32 |
$54,276 |
D/D |
8,588 |
9,588 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-06-09 |
4 |
OE |
$6.32 |
$55,300 |
D/D |
8,750 |
9,750 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-06-09 |
4 |
AS |
$40.00 |
$350,000 |
D/D |
(8,750) |
1,000 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
OE |
$6.55 |
$61,406 |
D/D |
9,375 |
30,979 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
AS |
$39.71 |
$372,281 |
D/D |
(9,375) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-04-20 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
1,000 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-04-20 |
4 |
OE |
$4.07 |
$40,700 |
D/D |
10,000 |
11,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-08-17 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
1,000 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2020-08-17 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
11,000 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-03-09 |
4 |
AS |
$40.02 |
$402,425 |
D/D |
(10,000) |
21,064 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-03-09 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,064 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-03-10 |
4 |
AS |
$42.54 |
$425,400 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-03-10 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-04-06 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-04-06 |
4 |
AS |
$40.95 |
$409,500 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-04-07 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-04-07 |
4 |
AS |
$41.59 |
$416,505 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-05-11 |
4 |
AS |
$30.81 |
$315,342 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-05-11 |
4 |
OE |
$6.55 |
$65,500 |
D/D |
10,000 |
31,604 |
0 |
- |
|
110 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
